The factors found to have an impact on survival (or considered to be effective) including ages at diagnosis, menopausal status, tumor size, nodal status, ER status, PR status, TNM stages, FOXP3+ expression in cancer cells and TILs, and FOXP3+ Tregs, CD68+ Mφ, IL-17+ Th17 in both intratumoral and stromal sites were re-analyzed using Cox regression analyses. This evidence concerns the gene FOXP3 and cancer.